NCT05853640 Education and Exercise for Patients With Longstanding Hip and Groin Pain
| NCT ID | NCT05853640 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lund University |
| Condition | Hip Pain Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 122 participants |
| Start Date | 2023-07-24 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 122 participants in total. It began in 2023-07-24 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Longstanding hip and groin pain (LHGP) is a common and debilitating problem in young to middle aged individuals. These patients often get referred to orthopedic departments. Consensus statements on the management of these patients commonly recommend a physical therapist-led intervention as the first line intervention. However, the optimal content and delivery of this intervention is currently unknown. In this study we will compare the effectiveness of usual care (unstructured physical therapist-led intervention) to a semi-structured, progressive individualized physical therapist-led intervention on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department.
Eligibility Criteria
Inclusion Criteria: * Men and women aged 18-55 years * Referred to the Dept of Orthopedics due to hip and/or groin pain * Activity-related unilateral or bilateral groin pain \>3 months * Pain reproduced with the FADIR test. Exclusion Criteria: * Groin pain originating from any diagnosis with other treatment pathways, i.e., i) Acute traumatic hip injuries (such as hip dislocation, hip fractures); ii) Verified moderate or severe OA (Tönnis grade \>1); iii) Palpable hernia; iv) Low-back pain with a positive straight leg raise test and/or hip and groin pain provoked primarily by repeated motions of the lumbar spine; v) Sacroiliac joint pain with thigh thrust test. * Co-morbidities potentially interfering with treatment, i.e., i) Co-morbidities overriding the hip and groin-related symptoms and dysfunction (such as other acute lower limb injuries, rheumatoid arthritis etc), ii) Co-morbidities prohibiting physical activity and training (heart disease etc), iii) Current psycho-social disorders requiring treatment. * Other: i) History of drug abuse within the last year; ii) Not understanding the language of interest (Scandinavian languages, or English).
Contact & Investigator
Eva Ageberg, PhD
PRINCIPAL INVESTIGATOR
Lund University
Frequently Asked Questions
Who can join the NCT05853640 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Hip Pain Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05853640 currently recruiting?
Yes, NCT05853640 is actively recruiting participants. Contact the research team at eva.ageberg@med.lu.se for enrollment information.
Where is the NCT05853640 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT05853640 clinical trial?
NCT05853640 is sponsored by Lund University. The principal investigator is Eva Ageberg, PhD at Lund University. The trial plans to enroll 122 participants.